Savara added to the nasdaq biotechnology index

Langhorne, pa.--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the company was added to the nasdaq biotech index (nasdaq: nbi), effective prior to market open on monday, december 18, 2023. the nasdaq biotechnology index is designed to track the performance of a set of securities listed on the nasdaq stock market® (nasdaq®) that are classified as either biotechnology or pharmaceutical according to.
SVRA Ratings Summary
SVRA Quant Ranking